Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 5028-5035

  Mostefai, H Ahmed ^a   Agouni, Abdelali ^a   Carusio, Nunzia ^a   Mastronardi, M Letizia ^b   Heymes, Christophe ^a   Henrion, Daniel ^a   Andriantsitohaina, Ramaroson ^a   Carmen Martinez, M ^a,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CAVEOLIN 1; I KAPPA B ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; AORTA; BIOSYNTHESIS; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; METABOLISM; MOUSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; APOPTOSIS; CELL LINE; ENDOTHELIAL CELLS; HUMANS; LYMPHOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; XANTHINE OXIDASE;

EID: 44449106129     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.5028     Document Type: Article

References (42)

1. Holme, P. A., U. Orvim, and M. J. Harriers. 1997. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler. Thromb. Vasc. Biol. 17: 646-653.
2. Mallat, Z., B. Hugel, J. Ohan, G. Leseche, J. M. Freyssinet, and A. Tedgui. 1999. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99: 348-353.
3. Martínez, M. C., A. Tesse, F. Zobairi, and R. Andriantsitohaina. 2005. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am. J. Physiol. 288: H1004-H1009.
4. Hugel, B., M. C. Martínez, C. Kunzelmann, and J. M. Freyssinet. 2005. Membrane microparticles: two sides of the coin. Physiology 20: 22-27.
5. Mallat, Z., H. Benamer, B. Hugel, J. Benessiano, P. G. Steg, J. M. Freyssinet, and A. Tedgui. 2000. Elevated levels of shed membrane microparticles with proco- agulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843.
6. Boulanger, C. M., A. Scoazec, T. Ebrahimian, P. Henry, E. Mathieu, A. Tedgui, and Z. Mallat. 2001. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649 -2652.
7. Amabile, N., A. P. Guerin, A. Leroyer, Z. Mallat, C. Nguyen, J. Boddaert, G. M. London, A. Tedgui, and C. M. Boulanger. 2005. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J. Am. Soc. Nephrol. 16: 3381-3388.
8. Martin, S., A. Tesse, B. Hugel, M. C. Martínez, O. Morel, J. M. Freyssinet, and R. Andriantsitohaina. 2004. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 109: 1653-1659.
9. Meziani, F., A. Tesse, E. David, M. C. Martínez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina. 2006. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am. J. Pathol. 169: 1473-1483.
10. Van Wijk, M. J., R. Nieuwland, K. Boer, J. A. M. Van der Post, E. VanBavel, andA. Sturk. 2002. Microparticles subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am. J. Obstet. Gynecol. 187: 450-456.
11. Baj-Krzyworzeka, M., M. Majka, D. Pratico, J. Ratajczak, G. Vilaire, J. Kijowski, R. Reca, A. Janowska-Wieczorek, and M. Z. Ratajczak. 2002. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemo- taxis of hematopoietic cells. Exp. Hematol. 30: 450-459.
12. Martínez, M. C., F. Larbret, F. Zobairi, J. Coulombe, N. Debili, W. Vainchenker, M. Ruat, and J. M. Freyssinet. 2006. Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 108: 3012-3020.
13. Agouni, A., H. A. Mostefai, C. Porro, N. Carusio, J. Favre, V. Richard, D. Henrion, M. C. Martínez, and R. Andriantsitohaina. 2007. Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. FASEB J. 21: 2735-2741.
14. Tesse, A., M. C. Martínez, B. Hugel, K. Chalupsky, C. D. Muller, F. Meziani, D. Mitolo-Chieppa, J. M. Freyssinet, and R. Andriantsitohaina. 2005. Upregula- tion of proinflammatory proteins through NF-κB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler. Thromb. Vasc. Biol. 25: 2522-2527.
15. Rojas, A., H. Figueroa, L. Re, and M. A. Morales. 2006. Oxidative stress at the vascular wall: mechanistic and pharmacological aspects. Arch. Med. Res. 37: 436-448.
16. Brodsky, S. V., F. Zhang, A. Nasjletti, and M. S. Goligorsky. 2004. Endothelium- derived microparticles impair endothelial function in vitro. Am. J. Physiol. 286: H1910 -H1915.
17. 17.Janiszewski, M., A. O. Do Carmo, M. A. Pedro, E. Silva, E. Knobel, and F. R. Laurindo. 2004. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit. Care Med. 32: 818 -825.
18. Leroyer, A. S., H. Isobe, G. Leséche, Y. Castier, M. Wassef, Z. Mallat, B. R. Binder, A. Tedgui, and C. M. Boulanger. 2007. Cellular origins and throm- bogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49: 772-777.
19. De Iuliis, G. N., J. K. Wingate, A. J. Koppers, E. A. McLaughlin, and R. J. Aitken. 2006. Definitive evidence for the nonmitochondrial production of superoxide anion by human spermatozoa. J. Clin. Endocrinol. Metab. 91: 1968 -1975.
20. Sbaa, E., F. Frerart, and O. Feron. 2005. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc. Med. 15: 157-162.
21. Molina-Jimenez, M. F., M. I. Sanchez-Reus, and J. Benedi. 2003. Effect of frax- etin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine. Eur. J. Pharmacol. 472: 81-87.
22. Liu, H., D. Song, and S. S. Lee. 1999. Increased nitric oxide expression in aorta of cirrhotic rats. Life Sci. 64: 1753-1759.
23. Busse, R., and I. Fleming. 2006. Vascular endothelium and blood flow. Handb. Exp. Pharmacol. 176: 43-78.
24. Fallon, M. B., J. A. Abrams, B. Luo, Z. Hou, J. Dai, and D. D. Ku. 1997. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepa- topulmonary syndrome. Gastroenterology 113: 606 -614.
25. Tazi, K. A., R. Moreau, J. Heller, O. Poirel, and D. Lebrec. 2000. Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas. Gastroenterology 119: 201-210.
26. Sumi, D., T. Hayashi, M. Jayachandran, and A. Iguchi. 2001. Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor α through estrogen receptor mediated system. Life Sci. 69: 1651-1660.
27. Gelinas, D. S., P. N. Bernatchez, S. Rollin, N. G. Bazan, and M. G. Sirois. 2002. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K: PKC and PLC pathways. Br. J. Pharmacol. 137: 1021-1030.
28. Go, M., H. Park, M. C. Maland, V. M. Darley-Usmar, B. Stoyanov, R. Wetzker, and H. Jo. 1998. Phosphatidylinositol 3-kinase γ mediates shear stress-dependent activation of JNK in endothelial cells. Am. J. Physiol. 275: H1898 -H1904.
29. Chen, D. B., I. M. Bird, J. Zheng, and R. R. Magness. 2004. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery en- dothelial cells. Endocrinology 145: 113-125.
30. Liu, W., Y. Liu, and W. L. Lowe, Jr. 2001. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase in insulin-like growth factor- I-mediated effects in vascular endothelial cells. Endocrinology 142: 1710 -1719.
31. Bernatchez, P. N., B. G. Allen, D. S. Gelinas, G. Guillemette, and M. G. Sirois. 2001. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. Br. J. Pharmacol. 134: 1253-1262.
32. Igarashi, J., S. G. Bernier, and T. Michel. 2001. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase: differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem. 276: 12420 -12426.
33. Naoum, J. J., S. Zhang, K. J. Woodside, W. Song, Q. Guo, L. M. Belalcazar, and G. C. Hunter. 2004. Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin. Surgery 136: 323-328.
34. Woodman, O. L., M. A. Missen, and M. Boujaoude. 2004. Daidzein and 17 β-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J. Cardiovasc. Pharmacol. 44: 155-163.
35. Sanchez, M., M. Galisteo, R. Vera, I. C. Villar, A. Zarzuelo, J. Tamargo, F. Perez-Vizcaino, and J. Duarte. 2006. Quercetin downregulates NADPH oxi- dase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J. Hypertens. 24: 75-84.
36. Newcomb, L. F., and C. C. Mastick. 2002. Src family kinase-dependent phos- phorylation of a 29-kDa caveolin-associated protein. Biochem. Biophys. Res. Commun. 290: 1447-1453.
37. Li, S., J. Couet, and M. P. Lisanti. 1996. Src tyrosine kinases: Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveo- lin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271: 29182-29190.
38. Li, S., R. Seitz, and M. P. Lisanti. 1996. Phosphorylation of caveolin by src tyrosine kinases: the a-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271: 3863-3868.
39. Shajahan, A. N., B. K. Timblin, R. Sandoval, C. Tiruppathi, A. B. Malik, and R. D. Minshall. 2004. Role of Src-induced dynamin-2 phosphorylation in caveo- lae-mediated endocytosis in endothelial cells. J. Biol. Chem. 279: 20392-20400.
40. Yung, L. M., F. P. Leung, X. Yao, Z. Y. Chen, and Y. Huang. 2006. Reactive oxygen species in vascular wall. Cardiovasc. Hematol. Disord. Drug Targets 6: 1-9.
41. Spiekermann, S., U. Landmesser, S. Dikalov, M. Bredt, G. Gamez, H. Tatge, N. Reepschlager, B. Hornig, H. Drexler, and D. G. Harrison. 2003. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodi- lation. Circulation 107: 1383-1389.
42. Butler, R., A. Morris, J. J. Belch, A. Hill, and A. D. Struthers. 2000. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746 -751.